N/A N=42 Supportive Care

Investigating the Experience of Living With Down Syndrome and Obstructive Sleep Apnea Syndrome (Stage 1)

Down Syndrome · Obstructive Sleep Apnea

Bottom Line

View on ClinicalTrials.gov: NCT04124471 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Apr 2023

Primary outcome: Primary: Number of Participants Who Completed Interviews Regarding Positive Airway Pressure (PAP) Acceptability — 20; 21 Participants

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Open-ended semi-structured interviews (Behavioral)
Age: Pediatric · 6+ yrs
Sex: All
Sponsor: Children's Hospital of Philadelphia
Primary completion: Jan 2022

Outcome Measures

Outcome	Result	p-value
PRIMARY Number of Participants Who Completed Interviews Regarding Positive Airway Pressure (PAP) Acceptability	20; 21	—

Summary

To identify the perceptions, beliefs, and family-relevant outcomes regarding the treatment of obstructive sleep apnea syndrome (OSAS) with positive airway pressure (PAP) in children with Down's Syndrome (DS).

Eligibility Criteria

Inclusion Criteria -- Patients

Children with DS and OSAS treated with PAP for at least 6 months
Children aged between 6 and 17.5 years
English proficiency

Inclusion Criteria -- Caregivers

Parent or legal guardian of an eligible patient subject
English proficiency
Must live with the patient subject at least 4 nights of the week

Exclusion Criteria -- Patients

In foster care
Diagnosed with major illness, such as leukemia or severe cyanotic congenital heart disease listed for cardiac transplant as these severe diseases may add confounders

Exclusion Criteria -- Caregivers

Foster parent

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04124471). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.